Heather Bresch: The Controversial Business Leader
Early Life and Career
Heather Bresch was born on June 27, 1969, in West Virginia. Her father is former coal baron and current West Virginia senator Joe Manchin. She graduated from West Virginia University with a degree in journalism. After working in various marketing and sales roles, Bresch joined the pharmaceutical company Mylan in 1998.
Rise to CEO
In 2012, Bresch was named CEO of Mylan. Under her leadership, the company's share price soared, and she was hailed as a successful businesswoman. However, Bresch also faced criticism for her handling of the EpiPen pricing scandal.
EpiPen Pricing Controversy
In 2016, Mylan was accused of raising the price of the EpiPen, a life-saving allergy treatment, by over 400%. Bresch was criticized for her role in the price increase, and she faced calls to resign as CEO.
Senate Investigation and Settlement
The Senate investigated Mylan's EpiPen pricing practices, and in 2017, the company reached a $465 million settlement with the Department of Justice. Bresch was not charged with any wrongdoing, but she did step down as CEO in 2019.
Compensation and Net Worth
Despite the controversy surrounding her tenure at Mylan, Bresch received a significant compensation package. In 2015, she earned $19 million in salary and perks, including a $3 million bonus. Her net worth is estimated to be over $31 million.
Legacy
Heather Bresch will likely be remembered for her role in the EpiPen pricing scandal. While she was a successful business leader, her legacy is tainted by the controversy surrounding her tenure at Mylan.
Comments